Myeloid Cure takes original innovation as its core development principle, deeply engaging in the frontier field of the disease immune microenvironment, devoting its full efforts to discovering novel macrophage targets, and independently carrying out original immunotherapeutic R&D and industrial transformation.

Drawing on its proprietary research strength, the company has built a diversified immunotherapy innovation pipeline, precisely targeting two challenging therapeutic areas—autoimmune diseases and malignant tumors—and proactively developing a differentiated product portfolio that is world-first with globally exclusive rights. By continually achieving breakthroughs in research and innovation to build high-level technological barriers, its core R&D achievements have the potential to disrupt existing diagnostic and treatment paradigms and lead a new wave of innovation in the immunotherapeutics industry.

As a high-tech research and development center, the company has always regarded independent innovation as the foundation of its growth, comprehensively establishing an intellectual property protection system. To date, the company has filed 18 patent applications, including 12 invention patents, and has been granted 14 patents, including 8 invention patents. This dense portfolio of patents fully covers core original drug technologies, steadily driving the company's high-quality and sustainable development through a continuous stream of scientific and technological innovation.

Backed by strong independent innovation capabilities and highly promising development prospects, the company's innovation achievements have received authoritative recognition and policy support from governments at all levels. It has been successively selected for the "5213" Emerging Talent Project and the Industrialization Excellence Project, earned qualifications including National- and Provincial-level Technology-based SME and Zhejiang Provincial "Specialized, Refined, Distinctive, and Innovative" SME, and been recognized as a Municipal High-Tech R&D Center and a Provincial Enterprise Research Institute—its solid innovation strength widely acknowledged.